INOVIQ announced that it has successfully completed stage 1 of its development program for an exosome therapeutic for breast cancer. In this in vitro proof-of-concept (POC) study, immortalised...
Read More »INOVIQ announced that it has successfully completed stage 1 of its development program for an exosome therapeutic for breast cancer. In this in vitro proof-of-concept (POC) study, immortalised...
Read More »